Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts
Running, not enrolling · Phase 3
Conditions studied: Bronchiolitis Obliterans Syndrome (BOS)
In brief
The primary aims of this study is to determine the efficacy and tolerability of Extracorporeal Photopheresis (ECP) for the treatment of either Refractory Bronchiolitis Obliterans Syndrome (BOS) patients (258 at cessation of enrollment April 7, 2022) or Newly Diagnosed (22 as of enrollment Hold February 2022) Bronchiolitis Obliterans Syndrome patients after lung transplantation. In compliance with the Centers for Medicare and Medicaid Services' (CMS) Coverage with Evidence Development (CED) decision, the study will collect specified demographic, comorbidity, treatment, and outcome data exclusively for Medicare beneficiaries who are treated with ECP for either refractory or New BOS.
Key facts
- Study ID
- NCT02181257
- Run by
- Washington University School of Medicine
- People needed
- 280
- Starts
- 2015-01-01
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2026-04-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
- University of California San Diego — La Jolla, California, United States
- University of Florida — Gainsville, Florida, United States
- Northwestern University — Chicago, Illinois, United States
- Indiana University Health — Indianapolis, Indiana, United States
- University of Iowa — Iowa City, Iowa, United States
- University of Kentucky — Lexington, Kentucky, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- University of Michigan Health System — Ann Arbor, Michigan, United States
- Spectrum Health — Grand Rapids, Michigan, United States
- University of Minnesota Medical Center, Fairview — Minneapolis, Minnesota, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Columbia University — New York, New York, United States
- Duke University — Durham, North Carolina, United States
- Ohio State University — Columbus, Ohio, United States
- Temple University — Philadelphia, Pennsylvania, United States
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
- Baylor University Medical Center — Dallas, Texas, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
- Houston Methodist — Houston, Texas, United States
- Inova Health System — Falls Church, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.